Bicocca Open Archive

Logo unimib boa
OGGIONI, NORBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.209
AS - Asia 8.394
EU - Europa 6.124
SA - Sud America 1.062
AF - Africa 197
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 22
Totale 29.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.848
SG - Singapore 3.292
CN - Cina 1.813
DE - Germania 1.087
HK - Hong Kong 1.043
RU - Federazione Russa 943
VN - Vietnam 885
SE - Svezia 871
BR - Brasile 783
IT - Italia 688
IE - Irlanda 676
UA - Ucraina 560
GB - Regno Unito 377
FR - Francia 292
IN - India 269
CA - Canada 253
KR - Corea 186
FI - Finlandia 172
BD - Bangladesh 134
AT - Austria 117
ID - Indonesia 110
AR - Argentina 106
TR - Turchia 96
JP - Giappone 88
IQ - Iraq 76
DK - Danimarca 69
ZA - Sudafrica 69
MX - Messico 67
NL - Olanda 55
PK - Pakistan 53
ES - Italia 52
PL - Polonia 47
MY - Malesia 42
SA - Arabia Saudita 42
PH - Filippine 41
EC - Ecuador 35
CO - Colombia 34
VE - Venezuela 29
IR - Iran 27
CL - Cile 24
BE - Belgio 22
AU - Australia 21
EG - Egitto 20
MA - Marocco 20
PY - Paraguay 20
UZ - Uzbekistan 20
ET - Etiopia 19
NZ - Nuova Zelanda 19
EU - Europa 18
KZ - Kazakistan 18
KE - Kenya 17
LT - Lituania 17
AE - Emirati Arabi Uniti 16
JO - Giordania 16
NP - Nepal 16
TN - Tunisia 16
TH - Thailandia 15
CH - Svizzera 14
UY - Uruguay 14
AZ - Azerbaigian 12
OM - Oman 11
IL - Israele 10
CZ - Repubblica Ceca 9
PE - Perù 9
PS - Palestinian Territory 9
AL - Albania 7
BG - Bulgaria 7
BH - Bahrain 7
BO - Bolivia 7
JM - Giamaica 7
KG - Kirghizistan 7
LB - Libano 7
AO - Angola 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
GE - Georgia 6
NG - Nigeria 6
PA - Panama 6
RS - Serbia 6
TW - Taiwan 6
DZ - Algeria 5
HR - Croazia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
HU - Ungheria 4
MD - Moldavia 4
RO - Romania 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
GT - Guatemala 3
HN - Honduras 3
KW - Kuwait 3
MM - Myanmar 3
NO - Norvegia 3
PT - Portogallo 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CI - Costa d'Avorio 2
Totale 29.013
Salva come PNG Salva come JPEG
Città #
Singapore 2.065
Ann Arbor 1.879
Ashburn 997
Hong Kong 997
San Jose 900
Woodbridge 819
Chandler 706
Dublin 654
Jacksonville 550
Houston 535
Frankfurt am Main 489
Fairfield 456
Wilmington 448
Dearborn 424
New York 344
Dallas 343
Beijing 271
Santa Clara 268
Milan 265
Ho Chi Minh City 249
Princeton 244
Los Angeles 237
Chicago 210
The Dalles 200
Hanoi 183
Seattle 180
Nanjing 178
Boardman 174
Council Bluffs 161
Cambridge 138
Shanghai 133
Seoul 131
Hefei 120
Vienna 111
Lauterbourg 110
Lachine 89
Buffalo 86
Dong Ket 78
Guangzhou 78
Jakarta 77
Moscow 75
Altamura 73
Lawrence 71
Orem 67
Nanchang 59
São Paulo 59
Munich 54
Toronto 54
Helsinki 53
Fremont 45
Shenyang 44
Andover 42
Tokyo 41
Grafing 40
Jinan 40
Zhengzhou 37
Da Nang 36
Jiaxing 36
Johannesburg 34
Nürnberg 33
San Diego 32
Tianjin 32
Baghdad 31
Changsha 31
Chennai 31
Montreal 30
Phoenix 30
Rio de Janeiro 30
London 29
Pune 29
Brooklyn 28
Atlanta 27
Columbus 27
Denver 26
Falls Church 26
Ottawa 26
Haiphong 25
Daejeon 24
Hangzhou 24
Kunming 24
Ankara 23
Mountain View 23
Warsaw 23
Hebei 22
Nuremberg 22
Basingstoke 21
Brussels 21
Istanbul 21
Dhaka 20
Philadelphia 20
Sacramento 20
Tashkent 20
Addis Ababa 19
Boston 19
Stockholm 19
Turku 19
Rome 18
Lahore 17
Poplar 17
Leawood 16
Totale 18.532
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 490
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 445
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 425
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 421
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 416
Age-related changes in the function and structure of the peripheral sensory pathway in mice 412
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 404
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 400
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 390
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 378
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 367
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 339
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 331
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 321
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 315
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 307
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 307
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 306
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 305
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 303
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 297
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 297
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 296
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 290
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 290
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 289
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 289
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 288
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 287
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 285
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 285
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 283
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 281
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 280
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 277
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 269
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 264
Effect of proteasome inhibition on the central and peripheral nervous system 262
Multimodal experimental approach to the study of human neurological diseases 260
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 259
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 256
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 254
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 251
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 248
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 246
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 245
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 245
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 244
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 243
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 243
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 243
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 242
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 241
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 241
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 240
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 239
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 239
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 236
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 235
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 234
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 234
Lipoplatin tm: a less neurotoxic formulation of cisplatin 233
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 232
Granulocytes in actively induced Lewis rat EAE 231
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 230
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 228
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 226
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 225
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 224
Erythropoietin both protects from and reverses experimental diabetic neuropathy 224
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 222
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 221
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 218
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 217
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 216
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 214
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 211
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 209
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 209
Regression of diabetic complications by islet transplantation in the rat 208
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 208
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 207
Cisplatin-induced painful peripheral neuropathy severity is strain-dipendent in mice: dissecting the role of pharmacogenomics. 204
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 204
Biodistrubution and toxicology of two PFCs intravenously injected in rats 201
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 200
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 198
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 196
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 194
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 193
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 193
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 188
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 188
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 187
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 187
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 186
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 182
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 181
Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models 179
The new analgesic CR4056 effectively abrogates neuropathic pain induced by Bortezomib in rats 177
Totale 26.160
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021368 0 0 0 0 0 0 0 0 0 0 132 236
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.668 297 735 235 260 199 431 34 139 214 30 52 42
2023/20242.035 65 62 79 67 274 536 351 89 101 40 23 348
2024/20254.492 283 607 355 210 350 119 203 169 477 616 416 687
2025/202610.199 1.143 684 911 923 1.173 747 1.887 614 1.010 1.008 99 0
Totale 29.955